A volatile mix of eroding insurance enrollment, record-breaking deductible hikes, and a fierce lobbying war between healthcare giants has left millions of Americans facing a deepening affordability crisis, according to latest industry data and federal reports.
The Affordable Care Act (ACA) marketplace is currently experiencing significant sticker shock as average premiums jumped 26% this year, following the expiration of enhanced federal subsidies. Policy experts warn that this is leading to a significant contraction of the individual market, with enrollment projected to end up 17% to 26% lower than last year.
The instability is particularly acute in states like Georgia, which saw a 28% drop in premium payments this April compared to the previous year. Nationwide, approximately 21% of people using the federal marketplace failed to pay their January premiums, a figure far higher than historical averages. The average ACA plan deductible saw its steepest increase in history, growing by 37% to reach $3,786 for the 2026 cycle.
Sabrina Corlette, co-director of the Center on Health Insurance Reforms at Georgetown University, said it is no surprise to see ACA participation fall. “In economic theory, no matter whether one is left, right, or center, it’s a simple fact that when you raise prices of something, fewer people will buy it,” Corlette told CBS News.
Analysts point to the “One Big Beautiful Bill Act,” a Republican spending package enacted last year, as a primary driver of these shifts. The legislation included provisions expected to reduce ACA enrollment and enacted nearly $1 trillion in cuts to Medicaid, the insurance program for low-income populations. Consequently, insurers are signaling further double-digit rate increases for 2027 to compensate for a smaller, and likely sicker, pool of enrollees.
The Three-Way Lobbying War
As costs mount, a high-profile clash has erupted among Washington’s most powerful lobbies: drugmakers, insurers, and hospitals. Each sector is attempting to deflect blame for the $5 trillion Americans spend annually on healthcare.
Hospitals are increasingly taking the fall, with insurers and drugmakers alleging that hospital consolidation is the primary engine of price inflation.
Recent data shows that hospital services accounted for 40% of the growth in national healthcare spending between 2022 and 2024. In response, the Trump administration and congressional regulators are considering aggressive measures, including cutting Medicare fees and overhauling the 340B drug discount program. The 340B program, which requires manufacturers to provide discounted drugs to hospitals serving low-income patients, has ballooned to an $81 billion cost as of 2024.
Hospitals are hitting back at what they see as a ‘blame game’ which seeks to portray them as the major cause of rising costs.
Charlene MacDonald, CEO of the Federation of American Hospitals said: “Tax-paying hospitals invest in their communities, provide more charity care than the national average, while facing chronic underpayments from Medicare and Medicaid, rising drug costs, and increasing administrative burdens created by insurers.”
President Donald Trump has moved to counter high costs by targeting prescription drug prices through a series of executive actions and platform expansions. On May 18, 2026, the White House announced the expansion of TrumpRx.gov, a platform designed to provide “unprecedented price transparency.”
The site now features more than 600 generic medications, including common treatments for cholesterol, diabetes, and high blood pressure. By integrating discounts from private programs like Amazon Pharmacy and GoodRx, the administration aims to help patients find the most competitive cash prices while bypassing insurance middlemen.
Furthermore, the administration has secured 17 deals with major pharmaceutical manufacturers to implement “Most-Favored-Nation” pricing. These agreements are intended to bring U.S. drug prices in line with the lowest prices paid in other developed nations. A landmark deal with the United Kingdom is also expected to increase drug prices in that country by 25%, ensuring other nations “pay their fair share” for medical innovation.
While generic drug prices may see relief, retirees remain under heavy financial pressure. Medicare Part B premiums surged by 10% in 2026, reigniting fears about the erosion of fixed incomes.
For many seniors, out-of-pocket medical spending now consumes a “substantial chunk” of their resources. Recent studies indicate that the median retiree has only 71% of their Social Security benefit remaining after covering healthcare costs. With the Social Security trust fund approaching depletion and policy markets remaining unstable, many retirees report that making ends meet has become increasingly difficult.
As traditional insurance becomes financially unviable for some, many researchers are turning to healthcare sharing as a community-driven, cost-effective alternative.
Unlike traditional insurance where premiums are paid to a private corporation, healthcare sharing involves a community of like-minded individuals, often from faith communities, who voluntarily contribute a set amount each month to help pay for one another’s eligible medical bills. This approach is rooted in shared values of generosity, compassion, and mutual responsibility.
The process typically centers on a monthly contribution, which is the fixed sum a member contributes to the sharing community. Members also have a specific annual amount a member is responsible for before certain shareable medical bills are eligible for sharing within the community.
Proponents argue that healthcare sharing offers affordability and flexibility, often providing access to broad provider networks and virtual care options.
Membership has grown from fewer than 200,000 people before 2010 to an estimated 1–1.5 million today, according to the Alliance of Health Care Sharing Ministries and a Colorado Division of Insurance analysis.
While not insurance – and not regulated as such – for those navigating the complex world of medical costs, this community-based model simplifies expenses by ensuring money goes directly to help another person rather than padding a corporate profit margin.